![Paul-Peter Tak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul-Peter Tak
Directeur Général chez
CANDEL THERAPEUTICS, INC.
Fortune : 2 M $ au 31/05/2026
Profil
Paul-Peter Tak is the founder of Sitryx Therapeutics Ltd., founded in 2016, serving as Director.
Dr. Tak is also the founder of MeiraGTx Netherlands BV..
Dr. Tak is President, Chief Executive Officer & Director at Candel Therapeutics, Inc. since 2020.
Dr. Tak is Chairman at Citryll BV since 2023.
Dr. Tak is Director at Levicept Ltd. since 2018.
Dr. Tak is Trustee at The Kennedy Trust for Rheumatology Research.
Formerly, Dr. Tak was President & Chief Executive Officer at Tempero Pharmaceuticals, Inc. from 2012 to 2015.
Dr. Tak was President & Chief Executive Officer at Senda Biosciences, Inc. from 2018 to 2020.
Dr. Tak was Director at ViiV Healthcare Ltd. from 2015 to 2018.
Dr. Tak was Director at Galvani Bioelectronics Ltd. from 2016 to 2018.
Dr. Tak was Director at Omega Therapeutics, Inc. from 2018 to 2020.
Dr. Tak was Chief Immunology Officer & Senior Vice President at GSK Plc from 2011 to 2018.
Dr. Tak was Venture Partner at Flagship Pioneering, LLC from 2018 to 2020.
Dr. Tak was Clinical Associate Professor at the University of California San Diego from 1999 to 2004.
Dr. Tak was Professor at the University of Amsterdam from 1999 to 2011.
Dr. Tak earned doctorates from Vrije Universiteit Amsterdam and the University of Leiden.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/04/2026 | 268 566 ( 0,37 % ) | 2 M $ | 31/05/2026 |
Postes actifs de Paul-Peter Tak
| Sociétés | Poste | Début |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Directeur Général | 01/09/2020 |
Sitryx Therapeutics Ltd.
 Sitryx Therapeutics Ltd. BiotechnologyHealth Technology Develop disease-modifying therapeutics for autoimmune and inflammatory disease | Fondateur | 08/09/2016 |
Citryll BV
 Citryll BV Miscellaneous Commercial ServicesCommercial Services Engages in development of therapeutic products to treat autoimmune and other human diseases | Président | 30/03/2023 |
Levicept Ltd.
 Levicept Ltd. Pharmaceuticals: GenericHealth Technology Develops treatments for osteoarthritis and chronic pain | Directeur/Membre du Conseil | 01/09/2018 |
The Kennedy Trust for Rheumatology Research
 The Kennedy Trust for Rheumatology Research Financial ConglomeratesFinance Provides financial support services for scientific research | Directeur/Membre du Conseil | - |
Anciens postes connus de Paul-Peter Tak
| Sociétés | Poste | Fin |
|---|---|---|
Senda Biosciences, Inc.
 Senda Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics to treat diseases | Directeur Général | 01/06/2020 |
| OMEA THER | Directeur/Membre du Conseil | 01/06/2020 |
Flagship Pioneering, Inc.
 Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Private Equity Investor | 01/06/2020 |
Galvani Bioelectronics Ltd.
 Galvani Bioelectronics Ltd. Pharmaceuticals: MajorHealth Technology Develops bioelectronic medicines | Directeur/Membre du Conseil | 01/09/2018 |
| ░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Paul-Peter Tak
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
75
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Amsterdam
 University of Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Leiden
 University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vrije Universiteit Amsterdam
 Vrije Universiteit Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Kennedy Trust for Rheumatology Research
The Kennedy Trust for Rheumatology Research Financial ConglomeratesFinance Provides financial support services for scientific research | Finance |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Candel Therapeutics, Inc.
 Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Tempero Pharmaceuticals, Inc.
 Tempero Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develop next-generation therapies that selectively suppress Th17-cells and enhance specialized Treg cells | Commercial Services |
Levicept Ltd.
Levicept Ltd. Pharmaceuticals: GenericHealth Technology Develops treatments for osteoarthritis and chronic pain | Health Technology |
MeiraGTx Netherlands BV
 MeiraGTx Netherlands BV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing local gene therapy for inflammatory diseases | Health Technology |
Galvani Bioelectronics Ltd.
Galvani Bioelectronics Ltd. Pharmaceuticals: MajorHealth Technology Develops bioelectronic medicines | Health Technology |
Sitryx Therapeutics Ltd.
Sitryx Therapeutics Ltd. BiotechnologyHealth Technology Develop disease-modifying therapeutics for autoimmune and inflammatory disease | Health Technology |
Omega Therapeutics, Inc.
 Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
Citryll BV
Citryll BV Miscellaneous Commercial ServicesCommercial Services Engages in development of therapeutic products to treat autoimmune and other human diseases | Commercial Services |
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics to treat diseases | Health Technology |
